Inventor · disambiguated record
Brydon L. Bennett
Also filed as: BENNETT BRYDON · BENNETT BRYDON L
15 granted patents·5 pending applications·169 citations·filing 2000–2022
93Inventor score
Top patents by PatentIndex Score
20 records- 0196US9701643B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Jul 11, 2017·19 cites·18 claims
- 0294US9139534B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithBENNETT BRYDON L·Filed 2012·Granted Sep 22, 2015·30 cites·76 claims
- 0393US10266500B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2018·Granted Apr 23, 2019·5 cites·14 claims
- 0493US7759342B2Methods of treatment and prevention using haloaryl substituted aminopurinesSIGNAL PHARM LLC·Filed 2007·Granted Jul 20, 2010·35 cites·7 claims
- 0589US10730880B24,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 4, 2020·4 cites·25 claims
- 0689US9556126B2Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2014·Granted Jan 31, 2017·10 cites·32 claims
- 0789US8440661B2Methods of modulating inflammatory cell recruitment and gene expression using haloaryl substituted aminopurinesBENNETT BRYDON L·Filed 2010·Granted May 14, 2013·21 cites·26 claims
- 0888US10428145B2PD-1 binding proteins and methods of use thereofCELGENE CORP·Filed 2016·Granted Oct 1, 2019·10 cites·155 claims
- 0983US8680076B2Methods of treatment, improvement and prevention using haloaryl substituted aminopurinesBENNETT BRYDON L·Filed 2011·Granted Mar 25, 2014·15 cites·18 claims
- 1082US7119114B1Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related theretoSIGNAL PHARM LLC·Filed 2000·Granted Oct 10, 2006·16 cites·19 claims
- 1180US12129237B2Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2022·Granted Oct 29, 2024·0 cites·6 claims
- 1279US9783505B2Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2016·Granted Oct 10, 2017·2 cites·29 claims
- 1378US10189845B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2015·Granted Jan 29, 2019·2 cites·20 claims
- 1470US2023272076A1PD-1 Binding Proteins and Methods of Use ThereofCELGENE CORP·Filed 2022·Application pending·0 cites
- 1564US11028093B24,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Jun 8, 2021·0 cites·19 claims
- 1661US2020255525A1Pd-1 binding proteins and methods of use thereofCELGENE CORP·Filed 2019·Application pending·0 cites
- 1758US2007060616A1Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compoundsSIGNAL PHARM LLC·Filed 2006·Application pending·0 cites
- 1853US7335676B2Methods for treating inflammatory conditions or inhibiting JNKSIGNAL PHARM LLC·Filed 2003·Granted Feb 26, 2008·0 cites·6 claims
- 1947US2005266391A1Methods for preserving tissueBENNETT BRYDON L·Filed 2005·Application pending·0 cites
- 2046US2004072888A1Methods for treating inflammatory conditions or inhibiting JNKFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →